EX1 0.00% 1.1¢ exopharm limited

With a significant pullback from highs and news due imminently...

  1. 2,510 Posts.
    lightbulb Created with Sketch. 21
    With a significant pullback from highs and news due imminently from the Plexoval 11 study, I've been buying more.
    With positive news, we should see our first third party collaboration or perhaps a licensing agreement.


 
watchlist Created with Sketch. Add EX1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.